The effects of PACAP on neural cell proliferation

Regulatory Peptides

Volumn 137, Issue 1-2, 2006, Pages 50-57

  Meyer, Dieter K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Neural cell; PACAP gene; Proliferation

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PHOSPHOLIPASE C; PROTEIN KINASE C; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SONIC HEDGEHOG PROTEIN;

ARTICLE; BRAIN DEVELOPMENT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; DRUG BINDING SITE; DRUG EFFECT; DRUG RECEPTOR BINDING; INHIBITION KINETICS; NEOCORTEX; NERVE CELL; NEUROBLAST; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR CELL;

ANIMALS; CELL PROLIFERATION; HUMANS; NERVOUS SYSTEM; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE;

ERINACEIDAE;

EID: 33751017654     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.03.009     Document Type: Article

References (109)

1. Shuto Y., Uchida D., Onda H., and Arimura A. Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain. Regul Pept 67 (1996) 79-83
2. Waschek J.A., Casillas R.A., Nguyen T.B., DiCicco-Bloom E.M., Carpenter E.M., and Rodriguez W.I. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc Natl Acad Sci U S A 95 (1998) 9602-9607
3. Skoglösa Y., Takei N., and Lindholm D. Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain. Brain Res Mol Brain Res 65 (1999) 1-13
4. Jaworski D.M., and Proctor M.D. Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system. Brain Res Dev Brain Res 120 (2000) 27-39
5. Erhardt N.M., Fradinger E.A., Cervini L.A., Rivier J.E., and Sherwood N.M. Early expression of pituitary adenylate cyclase-activating polypeptide and activation of its receptor in chick neuroblasts. Endocrinology 142 (2001) 1616-1625
6. Graber M., and Burgunder J.M. Ontogeny of vasoactive intestinal peptide gene expression in rat brain. Anat Embryol (Berl) 194 (1996) 595-605
7. Brenneman D.E., Nicol T., Warren D., and Bowers L.M. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J Neurosci Res 25 (1990) 386-394
8. Lu N., and DiCicco-Bloom E.M. Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci U S A 94 (1997) 3357-3362
9. Gressens P., Paindaveine B., Hill J.M., Evrard P., and Brenneman D.E. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. Eur J Neurosci 10 (1998) 1734-1742
10. Lu N., Zhou R., and DiCicco-Bloom E. Opposing mitogenic regulation by PACAP in sympathetic and cerebral cortical precursors correlates with differential expression of PACAP receptor (PAC1-R) isoforms. J Neurosci Res 53 (1998) 651-662
11. Zupan V., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., Robberecht P., et al. Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis. J Neurochem 70 (1998) 2165-2173
12. Vaudry D., Gonzalez B.J., Basille M., Fournier A., and Vaudry H. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc Natl Acad Sci U S A 96 (1999) 9415-9420
13. Hansel D.E., May V., Eipper B.A., and Ronnett G.V. Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro. J Neurosci 21 (2001) 4625-4636
14. Lee M., Lelievre V., Zhao P., Torres M., Rodriguez W., Byun J.Y., et al. Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors. J Neurosci 21 (2001) 3849-3859
15. Erhardt N.M., and Sherwood N.M. PACAP maintains cell cycling and inhibits apoptosis in chick neuroblasts. Mol Cell Endocrinol 221 (2004) 121-134
16. Erhardt N.M., Haines L.R., Pearson T.W., and Sherwood N.M. Inhibition of PACAP activity by a receptor antagonist results in changes in cell cycle and apoptotic proteins in chick neuroblasts. J Mol Neurosci 27 (2005) 107-123
17. Mercer A., Ronnholm H., Holmberg J., Lundh H., Heidrich J., Zachrisson O., et al. PACAP promotes neural stem cell proliferation in adult mouse brain. J Neurosci Res 76 (2004) 205-215
18. Meyer D.K., Fischer C., Becker U., Gottsching I., Boutillier S., Baermann C., et al. Pituitary adenylyl cyclase-activating polypeptide 38 reduces astroglial proliferation by inhibiting the GTPase RhoA. J Biol Chem 280 (2005) 25258-25266
19. DiCicco-Bloom E., Lu N., Pintar J.E., and Zhang J. The PACAP ligand/receptor system regulates cerebral cortical neurogenesis. Ann N Y Acad Sci 865 (1998) 274-289
20. Brenneman D.E., Eiden L.E., and Siegel R.E. Neurotrophic action of VIP on spinal cord cultures. Peptides 6 Suppl 2 (1985) 35-39
21. Hernandez A., Kimball B., Romanchuk G., and Mulholland M.W. Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells. Peptides 16 (1995) 927-932
22. Cavallaro S., Copani A., D'Agata V., Musco S., Petralia S., Ventra C., et al. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol 50 (1996) 60-66
23. Gressens P., Marret S., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 100 (1997) 390-397
24. Gonzalez B.J., Basille M., Vaudry D., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience 78 (1997) 419-430
25. Villalba M., Bockaert J., and Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17 (1997) 83-90
26. Vaudry D., Gonzalez B.J., Basille M., Anouar Y., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84 (1998) 801-812
27. Vaudry D., Rousselle C., Basille M., Falluel-Morel A., Pamantung T.F., Fontaine M., et al. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci U S A 99 (2002) 6398-6403
28. Waschek J.A. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev Neurosci 24 (2002) 14-23
29. Heraud C., Hilairet S., Muller J.M., Leterrier J.F., and Chadeneau C. Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins. J Neurosci Res 75 (2004) 320-329
30. Falluel-Morel A., Vaudry D., Aubert N., Galas L., Benard M., Basille M., et al. Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proc Natl Acad Sci U S A 102 (2005) 2637-2642
31. Leemhuis J., Henle F., Fischer C., and Meyer D.K. VIP/PACAP38 and NMDA facilitate dendrite formation by modifying the activities of the small Rho GTPases and phosphoinositide 3-kinase. Naunyn-Schmiedeberg's Arch Pharmacol 371 (2005) R31-R31
32. Hashimoto H., Shintani N., Tanaka K., Mori W., Hirose M., Matsuda T., et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A 98 (2001) 13355-13360
33. Gray S.L., Cummings K.J., Jirik F.R., and Sherwood N.M. Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15 (2001) 1739-1747
34. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 (1998) 265-270
35. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365 (1993) 170-175
36. Journot L., Waeber C., Pantaloni C., Holsboer F., Seeburg P.H., Bockaert J., et al. Differential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. Biochem Soc Trans 23 (1995) 133-137
37. Pantaloni C., Brabet P., Bilanges B., Dumuis A., Houssami S., Spengler D., et al. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271 (1996) 22146-22151
38. Chatterjee T.K., Sharma R.V., and Fisher R.A. Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels. J Biol Chem 271 (1996) 32226-32232
39. Ishihara T., Shigemoto R., Mori K., Takahashi K., and Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8 (1992) 811-819
40. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., and Harmar A.J. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334 (1993) 3-8
41. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52 (2000) 269-324
42. Grimaldi M., and Cavallaro S. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11 (1999) 2767-2772
43. Basille M., Vaudry D., Coulouarn Y., Jegou S., Lihrmann I., Fournier A., et al. Distribution of PACAP receptor mRNAs and PACAP binding sites in the rat brain during development. Ann NY Acad Sci 921 (2000) 304-307
44. Zhou C., Kikuyama S., Nakajo S., Hirabayashi T., Mizushima H., and Shioda S. Splice variants of PAC(1) receptor during early neural development of rats. Peptides 21 (2000) 1177-1183
45. Suh J., Lu N., Nicot A., Tatsuno I., and DiCicco-Bloom E. PACAP is an anti-mitogenic signal in developing cerebral cortex. Nat Neurosci 4 (2001) 123-124
46. Lelievre V., Pineau N., Du J., Wen C.H., Nguyen T., Janet T., et al. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase. J Biol Chem 273 (1998) 19685-19690
47. Nicot A., and DiCicco-Bloom E. Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression. Proc Natl Acad Sci U S A 98 (2001) 4758-4763
48. Lelievre V., Hu Z., Byun J.Y., Ioffe Y., and Waschek J.A. Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition. J Neurosci Res 67 (2002) 566-573
49. Pouyssegur J., and Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 270 (2003) 3291-3299
50. Sebolt-Leopold J.S., and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4 (2004) 937-947
51. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
52. Assoian R.K. Anchorage-dependent cell cycle progression. J Cell Biol 136 (1997) 1-4
53. Welsh C.F. Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation. Breast Cancer Res Treat 84 (2004) 33-42
54. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270 (1995) 23589-23597
55. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271 (1996) 20608-20616
56. Winston J.T., Coats S.R., Wang Y.Z., and Pledger W.J. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12 (1996) 127-134
57. Coleman M.L., Marshall C.J., and Olson M.F. RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol 5 (2004) 355-366
58. Balmanno K., and Cook S.J. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18 (1999) 3085-3097
59. Treinies I., Paterson H.F., Hooper S., Wilson R., and Marshall C.J. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol Cell Biol 19 (1999) 321-329
60. Suzuki T., Tsuzuku J., Ajima R., Nakamura T., Yoshida Y., and Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 16 (2002) 1356-1370
61. Gille H., and Downward J. Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 274 (1999) 22033-22040
62. Muise-Helmericks R.C., Grimes H.L., Bellacosa A., Malstrom S.E., Tsichlis P.N., and Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 273 (1998) 29864-29872
63. Diehl J.A., Cheng M., Roussel M.F., and Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12 (1998) 3499-3511
64. Bagui T.K., Mohapatra S., Haura E., and Pledger W.J. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol Cell Biol 23 (2003) 7285-7290
65. Barrie A.P., Clohessy A.M., Buensuceso C.S., Rogers M.V., and Allen J.M. Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a Ras-independent, mitogen-activated protein kinase/ERK kinase 1 or 2-dependent manner in PC12 cells. J Biol Chem 272 (1997) 19666-19671
66. Yang C., and Kazanietz M.G. Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol Sci 24 (2003) 602-608
67. Tognon C.E., Kirk H.E., Passmore L.A., Whitehead I.P., Der C.J., and Kay R.J. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol 18 (1998) 6995-7008
68. Toki S., Kawasaki H., Tashiro N., Housman D.E., and Graybiel A.M. Guanine nucleotide exchange factors CalDAG-GEFI and CalDAG-GEFII are colocalized in striatal projection neurons. J Comp Neurol 437 (2001) 398-407
69. Hashimoto H., Kunugi A., Arakawa N., Shintani N., Fujita T., Kasai A., et al. Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem Biophys Res Commun 311 (2003) 337-343
70. Dumaz N., and Marais R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J 272 (2005) 3491-3504
71. Vaudry D., Chen Y., Hsu C.M., and Eiden L.E. PC12 cells as a model to study the neurotrophic activities of PACAP. Ann NY Acad Sci 971 (2002) 491-496
72. Vaudry D., Stork P.J., Lazarovici P., and Eiden L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296 (2002) 1648-1649
73. Schmitt J.M., and Stork P.J. PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 9 (2002) 85-94
74. Dumaz N., and Marais R. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J Biol Chem 278 (2003) 29819-29823
75. Sewing A., Burger C., Brusselbach S., Schalk C., Lucibello F.C., and Muller R. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci 104 Pt 2 (1993) 545-555
76. Kato J.Y., Matsuoka M., Polyak K., Massague J., and Sherr C.J. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79 (1994) 487-496
77. L'Allemain G., Lavoie J.N., Rivard N., Baldin V., and Pouyssegur J. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14 (1997) 1981-1990
78. Balmanno K., Millar T., McMahon M., and Cook S.J. DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentry. Mol Cell Biol 23 (2003) 9303-9317
79. Kuiperij H.B., van der H.A., Raaijmakers J., Weijzen S., Medema R.H., Bos J.L., et al. Activation of FoxO transcription factors contributes to the antiproliferative effect of cAMP. Oncogene 24 (2005) 2087-2095
80. Carey R.G., Li B., and DiCicco-Bloom E.M. Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependent CDK2 activity. J Neurosci 22 (2002) 1583-1591
81. Marigo V., Davey R.A., Zuo Y., Cunningham J.M., and Tabin C.J. Biochemical evidence that patched is the Hedgehog receptor. Nature 384 (1996) 176-179
82. Stone D.M., Hynes M., Armanini M., Swanson T.A., Gu Q., Johnson R.L., et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384 (1996) 129-134
83. Rowitch D.H., Jacques B., Lee S.M., Flax J.D., Snyder E.Y., and McMahon A.P. Sonic hedgehog regulates proliferation and inhibits differentiation of CNS precursor cells. J Neurosci 19 (1999) 8954-8965
84. Wallace V.A. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol 9 (1999) 445-448
85. Dahmane N., Sanchez P., Gitton Y., Palma V., Sun T., Beyna M., et al. The Sonic hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 128 (2001) 5201-5212
86. Wechsler-Reya R.J. Caught in the matrix: how vitronectin controls neuronal differentiation. Trends Neurosci 24 (2001) 680-682
87. Ruiz i Altaba A., Palma V., and Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci 3 (2002) 24-33
88. Lai K., Kaspar B.K., Gage F.H., and Schaffer D.V. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6 (2003) 21-27
89. Kenney A.M., and Rowitch D.H. Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol 20 (2000) 9055-9067
90. Fan H., and Khavari P.A. Sonic hedgehog opposes epithelial cell cycle arrest. J Cell Biol 147 (1999) 71-76
91. Jensen A.M., and Wallace V.A. Expression of Sonic hedgehog and its putative role as a precursor cell mitogen in the developing mouse retina. Development 124 (1997) 363-371
92. Wechsler-Reya R.J., and Scott M.P. Control of neuronal precursor proliferation in the cerebellum by Sonic hedgehog. Neuron 22 (1999) 103-114
93. Nicot A., Lelievre V., Tam J., Waschek J.A., and DiCicco-Bloom E. Pituitary adenylate cyclase-activating polypeptide and Sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J Neurosci 22 (2002) 9244-9254
94. Schmidt A., and Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16 (2002) 1587-1609
95. Nobes C.D., and Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144 (1999) 1235-1244
96. Ridley A. Rho GTPases. Integrating integrin signaling. J Cell Biol 150 (2000) F107-F109
97. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology Rho GTPases control polarity, protrusion, and adhesion during cell movement. Nature 420 (2002) 629-635
98. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Biol Chem 271 (1996) 20246-20249
99. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 (1996) 245-248
100. Weber J.D., Hu W., Jefcoat Jr. S.C., Raben D.M., and Baldassare J.J. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J Biol Chem 272 (1997) 32966-32971
101. Hirai A., Nakamura S., Noguchi Y., Yasuda T., Kitagawa M., Tatsuno I., et al. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem 272 (1997) 13-16
102. Tanaka T., Tatsuno I., Noguchi Y., Uchida D., Oeda T., Narumiya S., et al. Activation of cyclin-dependent kinase 2 (Cdk2) in growth-stimulated rat astrocytes. Geranylgeranylated Rho small GTPase(s) are essential for the induction of cyclin E gene expression. J Biol Chem 273 (1998) 26772-26778
103. Laufs U., Marra D., Node K., and Liao J.K. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem 274 (1999) 21926-21931
104. Rivard N., Boucher M.J., Asselin C., and L'Allemain G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am J Physiol 277 (1999) C652-C664
105. Vidal A., Millard S.S., Miller J.P., and Koff A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J Biol Chem 277 (2002) 16433-16440
106. Hu W., Bellone C.J., and Baldassare J.J. RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity. J Biol Chem 274 (1999) 3396-3401
107. Olson M.F., Paterson H.F., and Marshall C.J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394 (1998) 295-299
108. McAllister S.S., Becker-Hapak M., Pintucci G., Pagano M., and Dowdy S.F. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 23 (2003) 216-228
109. Besson A., Gurian-West M., Schmidt A., Hall A., and Roberts J.M. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18 (2004) 862-876